Evidence map›Paper›PMID 24705566›Full record

ArticleMolecules (Basel, Switzerland)2014

Antioxidant and anticancer constituents from the leaves of Liriodendron tulipifera.

Ya-Fei Kang, Chi-Ming Liu, Chiu-Li Kao, Chung-Yi Chen

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Four Undescribed Pyranones from theMolecules (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Article
  6. Phytochemical Analysis and Dermo-Cosmetic Evaluation ofAntioxidants (Basel, Switzerland) · 2021
    Article
  7. Constituents from the Fruiting Bodies ofMolecules (Basel, Switzerland) · 2021
    Article
  8. Chemical Constituents of the Leaves ofPlants (Basel, Switzerland) · 2021
    Article
  9. Article
  10. The Phytochemistry of Cherokee Aromatic Medicinal Plants.Medicines (Basel, Switzerland) · 2018
    Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ya-Fei KangDepartment of Health Beauty, School of Medical and Health Sciences, Fooyin University, Ta-Liao District, Kaohsiung 83102, Taiwan. mt069@fy.edu.tw.
Chi-Ming LiuTzu Hui Institute of Technology, Pingtung County 92641, Taiwan. beagleliu@gmail.com.
Chiu-Li KaoDepartment of Health Beauty, School of Medical and Health Sciences, Fooyin University, Ta-Liao District, Kaohsiung 83102, Taiwan. beagleliu@gmail.com.
Chung-Yi ChenDepartment of Nutrition and Health Science, School of Medical and Health Sciences, Fooyin University, Ta-Liao District, Kaohsiung 83102, Taiwan. xx377@fy.edu.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sixteen compounds were extracted and purified from the leaves of Liriodendron tulipifera. These compounds include aporphines, oxoaporphine, coumarin, sesquiterpene lactone, benzenoids, cyclitol and steroids. (+)-Norstephalagine (2) (an aporphine) and scopoletin (8) (a coumarin) were isolated from Liriodendron tulipifera leaves from the first time. The identified compounds were screened for their antiradical scavenging, metal chelating and ferric reducing power activities. The results have showed that these compounds have antioxidative activity. The study has also examined the chemopreventive property of the isolated compounds against human melanoma cells A375. The results shown that (-)-anonaine (1), (-)-liridinine (3), (+)-lirinidine (6), lysicamine (7) and epitulipinolide diepoxide (9) significantly inhibited the proliferation of melanoma cells. These results revealed that these compounds have antioxidative activity and chemopreventive activity in skin melanoma cells.

Indexed as

AlkaloidsAntineoplastic Agents, PhytogenicAntioxidantsAporphinesCell Line, TumorDioxolesHumansLiriodendronPlant ExtractsPlant LeavesScopoletinAlkaloidsanonaineAntineoplastic Agents, PhytogenicAntioxidantsAporphinesDioxoleslirinidinelysicaminenorstephalaginePlant ExtractsScopoletin

Identifiers

PMID24705566
PMCPMC6271038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.